Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 26;8(1):e12340.
doi: 10.1002/trc2.12340. eCollection 2022.

A call for better reporting of trials using surrogate primary endpoints

Affiliations

A call for better reporting of trials using surrogate primary endpoints

Anthony Muchai Manyara et al. Alzheimers Dement (N Y). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts.

Figures

FIGURE 1
FIGURE 1
Project phases, timelines, activities in each phase (middle), with integrated knowledge translation (left) and patient and public involvement (right). Timelines include preparatory work before start of each phase. CONSORT, Consolidated Standards of Reporting Trials; RCT, randomized controlled trial; SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials

References

    1. Cummings J, Lee G, Nahed P, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimers Dementia (N Y). 2022;8:e12295. - PMC - PubMed
    1. Broich K. Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective. Int Psychogeriatr. 2007;19:509‐524. - PubMed
    1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89‐95. - PubMed
    1. Cummings JL, Goldman DP, Simmons‐Stern NR, Ponton E. The costs of developing treatments for Alzheimer's disease: a retrospective exploration. Alzheimers Dementia. 2022;18:469‐477. - PMC - PubMed
    1. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605‐613. - PubMed

LinkOut - more resources